l-carnitine and ammonia levels Management of late onset urea cycle disorders—a remaining challenge for the intensivist? | Annals of Intensive Care The Importance of the Fatty

In our chair, the patient who benefits most is someone who: Has the specific anatomical or skin concern this treatment addresses Has reasonable expectations about result magnitude and timeline Is willing to do the maintenance and aftercare Doesnt need a different treatment that would be more appropriate If any of the above are missing, we recommend something else

Wohlfarth C, Schmitteckert S, Hrtle JD, Houghton LA, Dweep H, Fortea M, et al

Zhang Q, Nguyen P, Burrell JC, Zeng J, Shi S, Shanti RM, et al

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance